Steven Johnson

Steven Johnson currently serves as the T Cell Receptor Antigen Map Project Manager at Adaptive Biotechnologies Corp., where the company collaborates with Microsoft to map and decode the human immune system. Prior experience includes a significant tenure at the Seattle Cancer Care Alliance, where Steven progressed through various leadership roles from Human Protection & Research Implementation Associate to Research Integration Leader, contributing to clinical research strategies as part of the Fred Hutch/UW Cancer Consortium. Earlier in career, Steven coordinated the Clinical Long-Term Follow-Up Program at Fred Hutch, expanding teleconsulting services for post-bone marrow transplant patients. Educational background includes studies at Western Washington University.